Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.
about
Defective cross-presentation of viral antigens in GILT-free micePathways of antigen processing.The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infectionInduction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virusB7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal diseaseDNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vectorLatent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory gangliaAge-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replicationInflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens.Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cellsCXCL10 expressing hematopoietic-derived cells are requisite in defense against HSV-1 infection in the nervous system of CXCL10 deficient mice.Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeCharacterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential V beta biasAntibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1Lytic Promoters Express Protein during Herpes Simplex Virus Latency.A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infectionRecognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsGlycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasivenessHuman CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigensHerpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.The role of chemokines during herpes simplex virus-1 infection.Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.Psychological stress exacerbates primary vaginal herpes simplex virus type 1 (HSV-1) infection by impairing both innate and adaptive immune responses.Psychological stress impairs the local CD8+ T cell response to mucosal HSV-1 infection and allows for increased pathogenicity via a glucocorticoid receptor-mediated mechanism.Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase.Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathwayInduction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.A subset of porcine reproductive and respiratory syndrome virus GP3 glycoprotein is released into the culture medium of cells as a non-virion-associated and membrane-free (soluble) form.Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection.
P2860
Q28592721-50B388ED-D1F0-4A63-B99B-65E46E585D5FQ33631854-248023FB-F177-4B95-9ED3-215C37D7FEF3Q33650076-8042A65E-4AFE-4924-84EF-5637C88C7426Q33784213-247D76D8-E083-4180-A69E-8A766B9140E9Q33785966-02B621B7-F37E-47D2-B223-781FE69CB0F1Q33799184-D79CCCB8-C876-4F52-9BC2-691CFD5A4B3BQ33874561-F9623C54-A4FC-4828-9EF8-2B62142B7241Q33985984-C943B1F6-C32A-4568-9E77-A1D229CEF3F1Q34069023-3C6061D5-46FE-472C-9364-5833C31E6ECDQ34142760-782893B7-8E74-435A-B6CD-3F5374B2CEB7Q34165203-14794684-DEF7-45FA-85D7-CE8E600DC972Q34165261-CF77CC80-D8E5-46F8-BB32-F7AA3E0B64B8Q34228659-54EF99CD-278E-4840-A9C4-22EB3A2EBE2FQ34472265-5E4F0306-C192-44D7-98A5-E27CEE5D697EQ34473170-F6B43DFA-2E11-46DA-9747-BE6EE6DE2F58Q34951110-D88F539A-22B1-42A0-AA0E-368337997DE8Q34975447-45EE9F20-D909-4BCF-BE63-659422A65C66Q34992660-134A5FD4-AFB3-4646-92C8-B85FC4343CB6Q35846244-9BEA3D7C-98C3-4B1B-A11A-A6834242B3D6Q35869527-6E5EE8BF-F3E0-4F17-ADAB-D069979789B3Q35882585-E7B71DB2-2D67-47AE-86B8-BAA4DCC603A7Q36062519-1690A613-8CD6-4452-93C0-AACFBB4CA34EQ36086635-A849FB69-17BE-4C5C-8119-0530CA648104Q36252465-49B6681C-367B-4B8D-81C8-461FE38E6B4BQ36640468-603CA6E2-73D4-4ADA-898A-6390BE622118Q36650065-25E3E9BA-3384-4C6D-9208-B5C4D3F560A4Q36653374-6902D27F-FFB9-4981-AA4A-EEFE33687E51Q36692634-001901AD-EF09-463B-B83B-CB5ACEADD13BQ36695109-7B612B17-1500-43A7-91ED-C45F55650114Q36726766-CF530BD8-308C-47A2-8939-712711C010FCQ37000682-4CA5B4D2-150E-4719-AB32-80197C31CCF3Q37041253-AAB2DE1D-2F2A-42D0-A835-301B7FF8CC89Q37041318-C89A4D97-08AD-4F9C-AE6B-5BEBDD34E1CAQ37127886-62C88531-76C1-43BF-A4E6-E97687AF0B86Q37170547-0FACDBBF-DDC8-4256-83A3-789299530947Q37411183-0628E5B7-5B44-4B2B-821A-97FF5EEA03A7Q39579222-CE757459-B1F8-4CCB-A614-EBEF092B7BDBQ39868823-40165BDA-EC51-4BA4-A7C3-5CC1902281E0Q39874070-51132003-494A-4498-9C60-B2AAEF0FF69BQ40042703-B3CB0AB9-AF96-4707-ADC0-97251FA1CF31
P2860
Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Identification of an immunodom ...... ectors and synthetic peptides.
@ast
Identification of an immunodom ...... ectors and synthetic peptides.
@en
type
label
Identification of an immunodom ...... ectors and synthetic peptides.
@ast
Identification of an immunodom ...... ectors and synthetic peptides.
@en
prefLabel
Identification of an immunodom ...... ectors and synthetic peptides.
@ast
Identification of an immunodom ...... ectors and synthetic peptides.
@en
P2093
P2860
P921
P1433
P1476
Identification of an immunodom ...... ectors and synthetic peptides.
@en
P2093
P2860
P304
P407
P577
1991-03-01T00:00:00Z